A previous immunohistochemical study showed a wide expression of Nectin-4 in different solid carcinomas ranging from Nectin-4 positivity in 55% of esophageal to 83% of bladder cancer with a moderate or high expression ranging from 18% in ovarian cancer to 60% in bladder cancer [26]. This evidence concerns the gene NECTIN4 and urinary bladder carcinoma.